Mitomycin: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Mitomycin. Educational only — not medical advice.
Labeled uses
Mitomycin for Injection, USP is not recommended as single-agent, primary therapy. It has been shown to be useful in the therapy of disseminated adenocarcinoma of the stomach or pancreas in proven combinations with other approved chemotherapeutic agents and as palliative treatment when other modalities have failed. Mitomycin is not recommended to replace appropriate surgery and/or radiotherapy.
Source: FDA labeling via NIH DailyMed (set 6a4fbc96…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.